Home โบ Calculator โบ BBOT Dividend Calculator 2026
BBOT Dividend DRIP Calculator 2026
22.17% YieldHealthcareBridgeBio Oncology Therapeutics Inc. ยท NASDAQ
Price: $9.02 ยท Annual div: $2.00/share ยท Frequency: quarterly ยท Payout ratio: 50% ยท Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
๐ก What-if scenarios
Click to apply scenario to the calculator
๐ฏ When BBOT pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your BBOT snowball ๐
$10,000 in BBOT โ $74.1K in 10 years ยท $1,120.52/month
About BridgeBio Oncology Therapeutics Inc. (BBOT) โ Dividend Analysis 2026
BridgeBio Oncology Therapeutics functions as a clinical-stage biopharmaceutical firm dedicated to pioneering advanced small molecule treatments. These therapies are aimed at combating malignancies driven by RAS and PI3Kฮฑ, both frequently encountered oncogenes in human cancers. Initially established as an offshoot of BridgeBio Pharma, the company concentrates on precision oncology. Its developmental pipeline features several promising programs, including BBO-8520, BBO-10203, and BBO-11818, all specifically designed to modulate the KRAS and PI3K pathways. The company recently became publicly traded through a business combination with Helix Acquisition Corp. II. This strategic move successfully raised approximately $450 million, which will be utilized to further its clinical development initiatives. The leadership team comprises Dr. Eli Wallace as Chief Executive Officer and Dr. Pedro Beltran as Chief Scientific Officer.
Compare BBOT with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full BBOT DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. ยท Privacy Policy
Ready to invest? Open BBOT position with:
๐ BBOT Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold BBOT.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| ๐บ๐ธ Roth IRA / 401k | 0% | 22.17% | 19.37% | $2,217 / yr |
| ๐บ๐ธ US Taxable (15%) โ | 15% | 18.84% | 16.04% | $1,884 / yr |
| ๐บ๐ธ US Taxable (20%) | 20% | 17.74% | 14.94% | $1,774 / yr |
| ๐ฌ๐ง UK ISA | 0% | 22.17% | 19.37% | $2,217 / yr |
| ๐ฌ๐ง UK Taxable | 8.75% | 20.23% | 17.43% | $2,023 / yr |
| ๐จ๐ฆ TFSA | 0% | 22.17% | 19.37% | $2,217 / yr |
| ๐จ๐ฆ CA Taxable | 25% | 16.63% | 13.83% | $1,663 / yr |
| ๐ฆ๐บ Super (pension) | 15% | 18.84% | 16.04% | $1,884 / yr |
| ๐ฆ๐บ AU Taxable | 30% | 15.52% | 12.72% | $1,552 / yr |
| ๐ฉ๐ช DE Taxable | 26.375% | 16.32% | 13.52% | $1,632 / yr |
| ๐ซ๐ท FR Taxable | 30% | 15.52% | 12.72% | $1,552 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
๐ฏ BBOT Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr ยท ๐บ๐ธ US Taxable (15%) ยท static projection (no growth assumed).
๐ BBOT Dividend Payment Schedule
BBOT pays quarterly โ 4 times per year. Next ex-div: TBD.
๐ BBOT vs Healthcare Benchmarks
How BBOT compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024โ2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for BBOT sourced from FMP /financial-growth endpoint โ real data, not estimates.
๐๏ธ BBOT Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| F-InKind | 2026-07-01 | 125 | $7.80 | $975.00 | ||
| F-InKind | 2026-07-01 | 343 | $7.80 | $2.7K | ||
| F-InKind | 2026-07-01 | 1,047 | $7.80 | $8.2K | ||
| F-InKind | 2026-07-01 | 1,047 | $7.80 | $8.2K | ||
| J-Other | 2026-07-01 | 130,865 | โ | โ | ||
| J-Other | 2026-07-01 | 1,704,862 | โ | โ | ||
| J-Other | 2026-07-01 | 2,692,459 | โ | โ | ||
| J-Other | 2026-07-01 | 4,528,186 | โ | โ | ||
| A-Award | 2026-06-16 | 31,675 | $7.73 | $244.8K | ||
| A-Award | 2026-06-16 | 31,675 | $7.73 | $244.8K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores โ lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the BBOT dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer โ
BridgeBio Oncology Therapeutics Inc. (BBOT) is currently trading at $9.02, 27% below its 52-week high. The current dividend yield is 22.17% based on an annual payout of $2.00 per share.
BBOT (BridgeBio Oncology Therapeutics Inc.) โ 22.17% Dividend Yield Analysis
BridgeBio Oncology Therapeutics Inc. (BBOT) is a healthcare stock currently trading at $9.02 with a dividend yield of 22.17%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (22.17%) may signal elevated risk โ verify sustainability.
Auto-generated from live market data. For educational purposes only โ not financial advice.